article thumbnail

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

Health Populi

Together, these patient groups represented about 19 million patients’ perspectives for 2021. The study explores patients’ views of the pharma industry as a whole as well as individual pharma companies by name, numbering 47 in this 2021 survey. Generics such as Mylan and Teva, among others.

BioTech 396
article thumbnail

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

Health Populi

Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. now, looking at health citizens’ trust in five segments of the health care industry between 2015 and 2021. in the first quarter of 2020. and around the world.

BioTech 317
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Healthcare, Heal Thyself! How the Industry Can and Should Play the Trust Card

Health Populi

The 2021 Edelman Trust Barometer spotlighted the infodemic and eroding trust in the U.S. also lost consumers’ trust during the pandemic, except for a handful of businesses — most notably, the health care industry gained a lot of American trust-equity from 2020 to 2021. Most industries operating in the U.S.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Patient engagement is measured by Consumer Assessment of Healthcare Processes and Services (CAHPS) surveys & Patient Activation Measures (PAM). Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Connect with her at [link].

BioTech 107
article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Why was this the case?

article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

in this moment, here’s a huge consensus for Americans on a single issue in 2021. The survey was fielded in June 2021 among 1,071 U.S. There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. Given our political chasms in the U.S.